title: Adjuvant intraoperative photodynamic therapy diminishes the rate of local recurrence in a rat mammary tumour model.
abstract: The use of photodynamic therapy (PDT) as an adjunct to curative tumour resection was investigated in a tumour recurrence model, using rat mammary adenocarcinoma BN472. Tumours were inoculated subcutaneously in 60 animals and resected after 21 days of growth. Immediately after removal, the operation site was exposed to 320-450 nm light of 0.1 W cm-2 and 60 J cm-2 after photosensitisation with either Photofrin (5 mg kg-1 i.v. 48 h before illumination) or 5-aminolaevulinic acid (ALA) (2 mg ml-1 in drinking water for 9 days). Porphyrin concentrations were measured in tissue samples. After 28 days, animals treated with adjunctive PDT had a significantly longer tumour-free interval than controls (P < 0.01); median 25 days (Photofrin), 18 days (ALA), 14 days (controls). Moreover, in the PDT groups significantly fewer rats had lymph node metastasis. A prophyrin concentration ratio between tumour and mammary tissue of 2:1 was found after Photofrin and 4:1 after ALA. The results indicate that adjuvant intraoperative PDT may be a safe and effective method of destroying residual tumour, thereby preventing locoregional tumour recurrence.
authors.affiliation: Department of Surgery, Erasmus University Rotterdam, Medical Faculty, The Netherlands.
authors.forename: R
authors.initials: R
authors.lastname: van Hillegersberg
authors.forename: J M
authors.initials: JM
authors.lastname: Hekking-Weijma
authors.forename: J H
authors.initials: JH
authors.lastname: Wilson
authors.forename: A
authors.initials: A
authors.lastname: Edixhoven-Bosdijk
authors.forename: W J
authors.initials: WJ
authors.lastname: Kort
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology / Q000601:surgery*; D000622:Aminolevulinic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D000704:Analysis of Variance; D000818:Animals; D017024:Chemotherapy, Adjuvant; D005260:Female; D005294:Ferrochelatase / Q000378:metabolism; D017324:Hematoporphyrin Derivative / Q000008:administration & dosage / Q000627:therapeutic use*; D011163:Hydroxymethylbilane Synthase / Q000378:metabolism; D008027:Light; D008207:Lymphatic Metastasis / Q000517:prevention & control; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000201:enzymology / Q000473:pathology / Q000601:surgery*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011166:Porphyrins / Q000378:metabolism; D051381:Rats; D011914:Rats, Inbred BN
chemical_list: D011166:Porphyrins; D017324:Hematoporphyrin Derivative; D000622:Aminolevulinic Acid; D011163:Hydroxymethylbilane Synthase; D005294:Ferrochelatase